Skip to main content
OpenTrials
Completed

NCT Number: NCT02486835

Efficacy & Tolerability of a Specific Plantain,Thyme and Honey Cough Syrup vs Placebo in Child Cough Due to Common Cold

Cough is a life saving reflex, therefore it is important, especially in pediatrics, to calm cough spells without sedating the reflex. The intent of this study is to use a protective syrup with does not act as a sedative or as a potent mucolytic and measure its efficacy and safety versus placebo in children with moderate to severe night and daily cough. Cough is assessed with a validated parent questionnaire. The degree of disturbance of cough is followed immediately after one night administration of the study products and daily for 4 nights, 3 days.

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 year–5 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Pediatric Ambulatory Clinic Bat-Yam, Bat Yam, Israel

Loading trial locations.

About this study

Cough is a life saving reflex, therefore it is important, especially in pediatrics, to calm cough spells without sedating the reflex. Looking into mechanisms for cough management different from mucolytics, or sedatives, such as protection of irritated pharynx mucosa from post nasal drip or other irritating substances is theoretically sound and shows practical interesting results.

A parallel comparison of efficacy and tolerability between such protective mechanism (acting through a barrier and radical scavenging action) due to natural substances (honey, plantago lanceolata and thymus vulgaris) and placebo has not been done so far, in very young children, especially in a time frame of 4 days. The intent of this study is to use the protective syrup versus placebo in children with moderate to severe night and daily cough, measured with a validated parent questionnaire. The degree of disturbance of cough is followed immediately after one night administration of the study products and daily for 4 nights, 3 days.

Assessment of effectiveness of the protective cough syrup as compared to placebo is considered very interesting due to the mechanism of the remedy.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • cough attributed to infection of the upper respiratory tract since less or equal than 7 days,
  • children aged 1 to 5 years
  • score of three or more of al least two of the following three questions relating to night cough, frequency of nocturnal cough, impact on sleep of child and impact on sleep of parent,
  • score of at least three of all questions assessing daytime cough considering the day prior to study entry
  • written consent by a parent.

Exclusion criteria

  • Children with a diagnosis of acute laryngotracheal bronchitis, pneumonia, asthma, sinusitis, allergic rhinitis, as well as chronic cardiac condition, or cystic fibrosis or any anatomical respiratory tract anomalies,
  • Children who received antihistamines or any cough medicine the day prior to study entry,
  • The administration of any steroid preparation by oral administration or inhalation on the day prior to study entry,
  • Known sensitivity to any component of placebo or to Plantago lanceolata or Thymus vulgaris, honey or any other component of the cough syrup.

Treatment and study plan

Cough syrup for adults and children

Device

Dosage is 5 ml three times a day for 4 nights, 3 days

Other names: Poliflav M.A.-honey cough syrup

PLACEBO

Device

Dosage is 5 ml three times a day for 4 nights, 3 days

Primary outcomes

  1. Change in night cough frequency score in the general population

    Time frame: baseline up to night 1

    Night cough frequency is the most invasive element of distress to the child and family. The questionnaire rating night cough is filled in each morning relating to the passed night for four nights. The basal night score is the score of the night before enrollment.

Secondary outcomes

  1. Change in night cough frequency score in the population coughing since 1-2 days

    Time frame: baseline up to night 1

    All these other elements constitute cough invasiveness into the quality of life of child and parents

  2. Change in night cough frequency score in the female population coughing since 1-2 days

    Time frame: baseline up to night 1

    All these other elements constitute cough invasiveness into the quality of life of child and parents

  3. Change in night cough frequency score in the male population coughing since 1-2 days

    Time frame: baseline up to night 1

    All these other elements constitute cough invasiveness into the quality of life of child and parents

  4. Change in night cough severity score in the general population

    Time frame: baseline up to night 1

    All these other elements constitute cough invasiveness into the quality of life of child and parents

  5. Change in night cough severity score in the population coughing since 1-2 days

    Time frame: baseline up to night 1

    All these other elements constitute cough invasiveness into the quality of life of child and parents

  6. Change in night cough bothersomeness score in the general population

    Time frame: baseline up to night 1

    All these other elements constitute cough invasiveness into the quality of life of child and parents

  7. Change in night cough bothersomeness score in the population coughing since 1-2 days

    Time frame: baseline up to night 1

    All these other elements constitute cough invasiveness into the quality of life of child and parents

  8. Change in night cough influence on sleep of child score in the general population

    Time frame: baseline up to night 1

    All these other elements constitute cough invasiveness into the quality of life of child and parents

  9. Change in night cough influence on sleep of child score in the population coughing since 1-2 days

    Time frame: baseline up to night 1

    All these other elements constitute cough invasiveness into the quality of life of child and parents

  10. Change in night cough influence on sleep of parent score in the general population

    Time frame: baseline up to night 1

    All these other elements constitute cough invasiveness into the quality of life of child and parents

  11. Change in night cough influence on sleep of parent score in the population coughing since 1-2 days

    Time frame: baseline up to night 1

    All these other elements constitute cough invasiveness into the quality of life of child and parents

  12. Change in night cough combined score in the general population

    Time frame: baseline up to night 1

    All these other elements constitute cough invasiveness into the quality of life of child and parents

  13. Change in night cough combined score in the population coughing since 1-2 days

    Time frame: baseline up to night 1

    All these other elements constitute cough invasiveness into the quality of life of child and parents

  14. Change in day cough frequency score in the general population

    Time frame: baseline up to day 2

    The questionnaire rating day cough is filled in each evening relating to the passed day for three days.

    The basal day score is the score of the day before enrollment.

Sponsors and collaborators

Lead sponsor

Clalit Health Services

Other

Registry information

Important dates

Study start
2015
Primary completion
2016
Study completion
2016
First posted
Jul 1, 2015
Registry last updated
Jan 29, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.